Cargando…
HER-2 overexpression/amplification in Barrett’s oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study
Barrett’s oesophagus (BO) is the primary precursor lesion for oesophageal adenocarcinoma (ADC). The natural history of metaplasia-dysplasia-carcinoma sequence remains largely unknown. HER2/neu oncogene results overexpressed/amplified in preneoplastic lesions and in ADC of the oesophagus and it has b...
Autores principales: | Rossi, Elisa, Grisanti, Salvatore, Villanacci, Vincenzo, Casa, Domenico Della, Cengia, Paolo, Missale, Guido, Minelli, Luigi, Buglione, Michela, Cestari, Renzo, Bassotti, Gabrio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516530/ https://www.ncbi.nlm.nih.gov/pubmed/19292734 http://dx.doi.org/10.1111/j.1582-4934.2008.00517.x |
Ejemplares similares
-
TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010) -
Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002) -
Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003) -
Optical Biopsy of Dysplasia in Barrett’s Oesophagus Assisted by Artificial Intelligence
por: van der Laan, Jouke J. H., et al.
Publicado: (2023) -
Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)